期刊文献+

消退素减轻肺部炎症的研究进展

The research progress of resolvin reducing pulmonary inflammation
原文传递
导出
摘要 背景适度的炎症反应是机体的一种保护性防御机制,而炎症反应失控会导致组织损伤。多不饱和脂肪酸衍生的脂类介质消退素具有抗炎症、促进炎症消退的功能,对肺部炎症性疾病,如急性肺损伤、哮喘、慢性阻塞性肺病等均有保护作用。目的通过总结近些年研究消退素在肺部炎性疾病中的作用,为其进一步研究奠定基础。内容介绍消退素的生成、分类及分子结构,总结消退素减轻肺部炎症的可能分子机制。趋向随着对消退素研究的深入,消退分子可能成为治疗肺部炎症性疾病的一种新型药物。 Background Moderate inflammatory response is a kind of protective defense mechanism, however, uncontrolled inflammation may give rise to tissue damage. Resolvin, a kind of polyunsaturated fatty acid-derived lipid mediator, exhibit anti-inflammatory and pro-resolving functions, which can alleviate pulmonary inflammatiory diseases, such as acute lung injury, asthma, chronic obstructive pulmonary disease. Objective This review lay the foundations for the research of Resolvin in pulmonary inflammatory diseases. Content This review describes the production, classification and molecular structure of Resolvin. In addition, we summarize the mechanisms of Resolvin in reducing pulmonary inflammatory diseases. Trend With the development in resolvin research, it's possible that pro-resolving mediators be a new drug in the treatment of pulmonary inflammatory diseases.
出处 《国际麻醉学与复苏杂志》 CAS 2014年第12期1120-1124,共5页 International Journal of Anesthesiology and Resuscitation
基金 国家自然科学基金(30930089,81372036)
关键词 消退素 炎症反应 肺部疾病 Resolvin Inflammation Pulmonary diseases
  • 相关文献

参考文献23

  • 1Levy BD. Resolvins and protectins: natural pharmacophores for resolution biology [J]. Prostaglandins Leukot Essent Fatty Acids, 2010, 82(4-6): 327-332.
  • 2王艳萍,吴艳,尚游,姚尚龙.促炎症消退脂质介质与炎症消退机制的研究进展[J].国际麻醉学与复苏杂志,2011,32(2):250-253. 被引量:2
  • 3Seki H, Fukunaga K, Arita M, et al. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury [J]. J Immunol, 2010, 184(2): 836-843.
  • 4Wang B, Gong X, Wan JY, et al. Resolvin DI protects mice from LPS-induced acute lung injury [J]. Pulm Pharmacol Ther, 2011, 24(4): 434-441.
  • 5Hisada T, Ishizuka T, Aoki H, et al. Resolvin El as a novel agent for the treatment of asthma [J]. Expert Opin Ther Targets, 2009, 13(5): 513-522.
  • 6Yang J, Eiserich JP, Cross CE, et al. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients[J]. Free Radic Biol Med, 2012, 53( 1 ): 160-171.
  • 7Noding LV, Dalli J, Flower RJ, et al. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci:receptor-dependent actions [J]. Arterioscler Thromb Vasc Biol, 2012, 32(8): 1970-1978.
  • 8Waechter V, Schmid M, Herova M, et al. Charaeterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages [J]. J Immunol, 2012, 188(4): 1856-1867.
  • 9Krishnamoorthy S, Recchiuti A, Chiang N, et at. Resolvin DI binds human phagocytes with evidence for proresolving receptors [J]. Proc Natl Acad Sci U S A, 2010, 107(4): 1660-1665.
  • 10Fredman G, Oh SF, Ayilavarapu S, et al. Impaired phagocytosis in localized aggressive periodontitis: rescue by resolvin E1 [J]. PLoS One, 2011, 6(9): e24422.

二级参考文献25

  • 1Serhan CN, Savill J. Resolution of irfflammation: the beginning programs the end. Nat Immunol, 2005, 6(12): 1191-1197.
  • 2Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti -inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids, 2005, 73(3- 4): 141-162.
  • 3Chiang N, Serhan CN, Dahl6n SE, et al. The lipoxin receptor ALX: potent ligand- specific and stcreoselective actions in vivo. Pharmacol Rev, 2006, 58(3): 463.-487.
  • 4Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti- inflammatory and pro-resolution lipid mediators. Nat Rev Immunol, 2008, 8(5): 349-361.
  • 5Ariel A, Chiang N, Arita M, et al. Aspirin-triggered lipoxin A4 and B4 analogs block extraeellular signal-regulated kinase- dependent TNF-alpha secretion from human T cells. J lmmunol, 2003, 170(12) : 626645272.
  • 6Herlong JL, Scott TR. Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol Lett, 2006, 102(2): 121-131.
  • 7Gilroy DW, Lawrence T, Perretti M, et al. Inflammatory" resolution: new opportunities for drug discovery. Nat lRev Drug Discov, 2004, 3(5): 401-416.
  • 8Zhang X, Wang JM, Gong WH, et al. Differential regulation of chemokine gene expression by 15-deoxy-delta 12, 14 prostaglandin J2. J Immunol, 2001, 166(12): 7104-7111.
  • 9Arlta M, Clish CB, Serhan CN. The contributions of aspirin andmicrobial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun, 2005, 338(1): 149-157.
  • 10Tjonahen E, Oh SF, Siegelman J, et al. Resolvin E2: identification and anti- inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol, 2006, 13(11): 1193-1202.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部